AstraZeneca, MRC Technology Partner With Charities on Lung Disease Research | GenomeWeb

NEW YORK (GenomeWeb) – British medical research charity MRC Technology announced today that it has partnered with Asthma UK, the British Lung Foundation, and AstraZeneca to study the link between epigenetics and respiratory disease, with the goal of discovering new treatments for asthma, chronic obstructive pulmonary disease, and other lung disorders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.